Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus
Abstract
The intraphagocytic effects of ciprofloxacin and BAY 12-8039 (moxifloxacin), a new 8-methoxyquinolone, on Staphylococcus aureus showing various susceptibility patterns were examined and the results were compared with the activities of the drugs against extracellular bacteria. MICs of moxifloxacin and ciprofloxacin against methicillin-resistant and -susceptible staphylococci were 0.063 mg/L and 0.5 mg/L, respectively. Moxifloxacin was also active against methicillin-resistant S. aureus (MIC = 2 mg/L) that were resistant to ciprofloxacin (MIC = 32 mg/L). At concentrations of 0.1 x or 1 x MIC, both drugs showed only weak bacteriostatic effects against ingested and non-ingested staphylococci. At 10 x MIC, ciprofloxacin and moxifloxacin were bactericidal against both intracellular and extracellular S. aureus susceptible to oxacillin and against MRSA susceptible to ciprofloxacin. However, ciprofloxacin was bactericidal only at very high concentrations ranging from 5 mg/L to 320 mg/L. Against ciprofloxacin-resistant MRSA moxifloxacin was still active. The results suggest that moxifloxacin is active against intracellular staphylococci.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.